Standard Biotools Stock Market Value
| LAB Stock | USD 1.82 0.11 6.43% |
| Symbol | Standard |
Standard Biotools Price To Book Ratio
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.558 | Quarterly Revenue Growth (0.14) | Return On Assets (0.15) | Return On Equity (0.37) |
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Standard Biotools 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Standard Biotools' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Standard Biotools.
| 12/09/2022 |
| 11/28/2024 |
If you would invest 0.00 in Standard Biotools on December 9, 2022 and sell it all today you would earn a total of 0.00 from holding Standard Biotools or generate 0.0% return on investment in Standard Biotools over 720 days. Standard Biotools is related to or competes with Star Equity, Biodesix, ENDRA Life, Fonar, MDxHealth, Inotiv, and Burning Rock. Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researche... More
Standard Biotools Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Standard Biotools' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Standard Biotools upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 17.67 | |||
| Value At Risk | (7.11) | |||
| Potential Upside | 6.62 |
Standard Biotools Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Standard Biotools' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Standard Biotools' standard deviation. In reality, there are many statistical measures that can use Standard Biotools historical prices to predict the future Standard Biotools' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.57) | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | (0.12) |
Standard Biotools Backtested Returns
Standard Biotools owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0397, which indicates the firm had a -0.0397% return per unit of risk over the last 3 months. Standard Biotools exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Standard Biotools' Variance of 16.05, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,429) to confirm the risk estimate we provide. The entity has a beta of 2.34, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Standard Biotools will likely underperform. At this point, Standard Biotools has a negative expected return of -0.16%. Please make sure to validate Standard Biotools' coefficient of variation, treynor ratio, skewness, as well as the relationship between the jensen alpha and value at risk , to decide if Standard Biotools performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.33 |
Poor reverse predictability
Standard Biotools has poor reverse predictability. Overlapping area represents the amount of predictability between Standard Biotools time series from 9th of December 2022 to 4th of December 2023 and 4th of December 2023 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Standard Biotools price movement. The serial correlation of -0.33 indicates that nearly 33.0% of current Standard Biotools price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.33 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.12 |
Standard Biotools lagged returns against current returns
Autocorrelation, which is Standard Biotools stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Standard Biotools' stock expected returns. We can calculate the autocorrelation of Standard Biotools returns to help us make a trade decision. For example, suppose you find that Standard Biotools has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Standard Biotools regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Standard Biotools stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Standard Biotools stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Standard Biotools stock over time.
Current vs Lagged Prices |
| Timeline |
Standard Biotools Lagged Returns
When evaluating Standard Biotools' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Standard Biotools stock have on its future price. Standard Biotools autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Standard Biotools autocorrelation shows the relationship between Standard Biotools stock current value and its past values and can show if there is a momentum factor associated with investing in Standard Biotools.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:Check out Standard Biotools Correlation, Standard Biotools Volatility and Standard Biotools Alpha and Beta module to complement your research on Standard Biotools. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Standard Biotools technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.